These findings exhibit strong alignment with our previous conclusions, leading us to hypothesize that AA likely ameliorates DKD by modulating metabolic pathways, particularly the STBD1-mediated glycogen metabolism pathway, which, in turn, regulates downstream inflammatory and fibrotic cascades. Here, STBD1 is linked to diabetic kidney disease.